Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PDX Pharmaceuticals logo — Delivery of Next-Gen Combination and Immunotherapies on Nano...

PDX Pharmaceuticals

Delivery of Next-Gen Combination and Immunotherapies on Nanotechnology Platform.

Founded 2010 United States Portland, United States 9 employees Series A Total: $1.55M Biotechnology, Health Care +1

General Information

Company Name PDX Pharmaceuticals
Founded Year 2010
Location United States Portland, United States +1
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

Get notified when PDX Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PDX Pharmaceuticals

PDX Pharmaceuticals is an IND-enabling stage biopharmaceutical company. We develop novel combination and immunotherapies to treat cancer by bringing complementary biological pathways together to achieve synergistic clinical benefit. Our therapeutic candidates bridge the innate and adaptive immune systems by generating profound CD8+ T cell production. Our pipelines are patented AIRISE (Augmenting Immune Responses and Inhibiting the Suppressive Environment of Tumors) and ARAC (Antigen Release Agent and Checkpoint Inhibitor) pipelines that generate anti-tumor immunity when given locally (AIRISE) or systemically (ARAC) by relying on patient' s own tumor in situ as the source of antigens.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
27 Nov 2019

PDX Pharmaceuticals Alternatives & Competitors

PDX Pharmaceuticals vs
Yixi Biotech
Yixi Biotech

Yixi Biotech specializes in providing advanced solutions in the intestinal microbiology sector. The...

Seed
Biotechnology, Health Care
PDX Pharmaceuticals vs
Batu Biologics, Inc.
Batu Biologics, Inc. United States

Batu Biologics is a biotechnology-based pharmaceutical company focused on the development and commer...

Equity Crowdfunding
3 employees
Biotechnology
PDX Pharmaceuticals vs
MACROPHAGE PHARMA LIMITED
MACROPHAGE PHARMA LIMITED

Empowering the immune system to combat cancer with precision-targeted therapies

Series A
Biotechnology, Pharmaceutical

FAQ About PDX Pharmaceuticals

Delivery of Next-Gen Combination and Immunotherapies on Nanotechnology Platform.
PDX Pharmaceuticals was founded in 2010.
PDX Pharmaceuticals is headquartered in Portland, United States.
PDX Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
PDX Pharmaceuticals has approximately 9 employees.
PDX Pharmaceuticals has completed 1 funding round, raising a total of $1.55M. The latest funding stage is Series A.
Top alternatives and competitors to PDX Pharmaceuticals include Yixi Biotech, Batu Biologics, Inc., MACROPHAGE PHARMA LIMITED, Duet BioTherapeutics, Immunophotonics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PDX Pharmaceuticals and Yixi Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PDX Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes